Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension
Phase 2
Withdrawn
- Conditions
- Pulmonary Hypertension
- First Posted Date
- 2006-05-09
- Last Posted Date
- 2007-08-30
- Lead Sponsor
- NITROX, LLC
- Target Recruit Count
- 72
- Registration Number
- NCT00323024
- Locations
- 🇺🇸
Christiana Care Health Services, Newark, Delaware, United States
🇺🇸University of Maryland, Baltimore, Maryland, United States
🇺🇸Arizona Pulmonary Specialists, Ltd., Phoenix, Arizona, United States
© Copyright 2025. All Rights Reserved by MedPath